Forte Biosciences, Inc.
NASDAQ:FBRX
6.73 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 18.036 | 0.041 | 0.049 | 0.051 |
| Cost of Revenue
| 0.009 | 0 | 0.036 | 0.054 | 0.011 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.009 | 0 | -0.036 | -0.054 | -0.011 | 18.036 | 0.041 | 0.049 | 0.051 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 21.862 | 5.594 | 13.853 | 10.004 | 2.684 | 50.455 | 29.113 | 27.218 | 19.172 |
| General & Administrative Expenses
| 10.624 | 8.302 | 7.633 | 4.221 | 1.38 | 0.266 | 8.557 | 4.522 | 3.833 |
| Selling & Marketing Expenses
| -0.009 | 0 | 0 | 0 | 0 | 12.543 | -0.292 | -0.255 | -0.232 |
| SG&A
| 10.615 | 8.302 | 7.633 | 4.221 | 1.38 | 12.809 | 8.265 | 4.267 | 3.601 |
| Other Expenses
| 0 | 0.017 | -0.222 | -0.205 | -0.007 | 0 | 0 | -0.05 | 0 |
| Operating Expenses
| 32.477 | 13.896 | 21.486 | 14.225 | 4.064 | 63.264 | 37.378 | 31.485 | 22.773 |
| Operating Income
| -32.486 | -13.896 | -21.486 | 17.832 | -4.064 | -45.853 | -37.629 | -31.691 | -22.954 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | -2.542 | -917.78 | -646.755 | -450.078 |
| Total Other Income Expenses Net
| 1.01 | 0.017 | -0.222 | -64.319 | -0.004 | -1.403 | -1.3 | -1.787 | -0.102 |
| Income Before Tax
| -31.476 | -13.879 | -21.708 | -46.487 | -4.069 | -47.256 | -38.929 | -33.478 | -23.056 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | -2.62 | -949.488 | -683.224 | -452.078 |
| Income Tax Expense
| 0 | -0.017 | -0.201 | 32.057 | -0.003 | 1.699 | -2.6 | -3.674 | -0.204 |
| Net Income
| -31.476 | -13.862 | -21.708 | -78.544 | -4.066 | -48.955 | -38.929 | -33.478 | -23.056 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | -2.714 | -949.488 | -683.224 | -452.078 |
| EPS
| -1 | -0.8 | -1.55 | -10.67 | -1.93 | -36.61 | -39.97 | -25.39 | -18.97 |
| EPS Diluted
| -1 | -0.8 | -1.55 | -10.67 | -1.93 | -36.61 | -39.97 | -25.39 | -18.97 |
| EBITDA
| -32.477 | -13.896 | -21.45 | 17.886 | -4.053 | -45.228 | -37.337 | -31.436 | -22.722 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | -2.508 | -910.659 | -641.551 | -445.529 |